Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.

We have isolated Clostridium perfringens type B, an epsilon toxin-secreting bacillus, from a young woman at clinical presentation of Multiple Sclerosis (MS) with actively enhancing lesions on brain MRI. This finding represents the first time that C. perfringens type B has been detected in a human. E...

Full description

Bibliographic Details
Main Authors: Kareem Rashid Rumah, Jennifer Linden, Vincent A Fischetti, Timothy Vartanian
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3797790?pdf=render
_version_ 1818409262074822656
author Kareem Rashid Rumah
Jennifer Linden
Vincent A Fischetti
Timothy Vartanian
author_facet Kareem Rashid Rumah
Jennifer Linden
Vincent A Fischetti
Timothy Vartanian
author_sort Kareem Rashid Rumah
collection DOAJ
description We have isolated Clostridium perfringens type B, an epsilon toxin-secreting bacillus, from a young woman at clinical presentation of Multiple Sclerosis (MS) with actively enhancing lesions on brain MRI. This finding represents the first time that C. perfringens type B has been detected in a human. Epsilon toxin's tropism for the blood-brain barrier (BBB) and binding to oligodendrocytes/myelin makes it a provocative candidate for nascent lesion formation in MS. We examined a well-characterized population of MS patients and healthy controls for carriage of C. perfringens toxinotypes in the gastrointestinal tract. The human commensal Clostridium perfringens type A was present in approximately 50% of healthy human controls compared to only 23% in MS patients. We examined sera and CSF obtained from two tissue banks and found that immunoreactivity to ETX is 10 times more prevalent in people with MS than in healthy controls, indicating prior exposure to ETX in the MS population. C. perfringens epsilon toxin fits mechanistically with nascent MS lesion formation since these lesions are characterized by BBB permeability and oligodendrocyte cell death in the absence of an adaptive immune infiltrate.
first_indexed 2024-12-14T09:56:49Z
format Article
id doaj.art-acbf910c142e49c4b7772813be362a55
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T09:56:49Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-acbf910c142e49c4b7772813be362a552022-12-21T23:07:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7635910.1371/journal.pone.0076359Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.Kareem Rashid RumahJennifer LindenVincent A FischettiTimothy VartanianWe have isolated Clostridium perfringens type B, an epsilon toxin-secreting bacillus, from a young woman at clinical presentation of Multiple Sclerosis (MS) with actively enhancing lesions on brain MRI. This finding represents the first time that C. perfringens type B has been detected in a human. Epsilon toxin's tropism for the blood-brain barrier (BBB) and binding to oligodendrocytes/myelin makes it a provocative candidate for nascent lesion formation in MS. We examined a well-characterized population of MS patients and healthy controls for carriage of C. perfringens toxinotypes in the gastrointestinal tract. The human commensal Clostridium perfringens type A was present in approximately 50% of healthy human controls compared to only 23% in MS patients. We examined sera and CSF obtained from two tissue banks and found that immunoreactivity to ETX is 10 times more prevalent in people with MS than in healthy controls, indicating prior exposure to ETX in the MS population. C. perfringens epsilon toxin fits mechanistically with nascent MS lesion formation since these lesions are characterized by BBB permeability and oligodendrocyte cell death in the absence of an adaptive immune infiltrate.http://europepmc.org/articles/PMC3797790?pdf=render
spellingShingle Kareem Rashid Rumah
Jennifer Linden
Vincent A Fischetti
Timothy Vartanian
Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
PLoS ONE
title Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
title_full Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
title_fullStr Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
title_full_unstemmed Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
title_short Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease.
title_sort isolation of clostridium perfringens type b in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease
url http://europepmc.org/articles/PMC3797790?pdf=render
work_keys_str_mv AT kareemrashidrumah isolationofclostridiumperfringenstypebinanindividualatfirstclinicalpresentationofmultiplesclerosisprovidescluesforenvironmentaltriggersofthedisease
AT jenniferlinden isolationofclostridiumperfringenstypebinanindividualatfirstclinicalpresentationofmultiplesclerosisprovidescluesforenvironmentaltriggersofthedisease
AT vincentafischetti isolationofclostridiumperfringenstypebinanindividualatfirstclinicalpresentationofmultiplesclerosisprovidescluesforenvironmentaltriggersofthedisease
AT timothyvartanian isolationofclostridiumperfringenstypebinanindividualatfirstclinicalpresentationofmultiplesclerosisprovidescluesforenvironmentaltriggersofthedisease